đ
A new study shows that an FDA-approved, pharmaceutical-grade formulation of CBD has an antiviral effect in human lung cells and mice, and shows a significant negative association with COVID infection in human patients.
Researchers recommend clinical trials for CBD to prevent COVID-19 based on promising animal data
Posted in biotech/medical